Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.14 USD | +5.72% | +5.02% | -25.42% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.42% | 665M | |
+29.60% | 48.16B | |
-0.69% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.61% | 18.96B | |
+9.02% | 12.92B | |
+29.25% | 12.03B | |
-1.90% | 11.77B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac : A missed opportunity